Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for ultrafiltration therapy. Nuwellis Inc., formerly known as CHF Solutions, is headquartered in Minneapolis, Minn.
| Revenue (Most Recent Fiscal Year) | $8.74M |
| Net Income (Most Recent Fiscal Year) | $-11.16M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.48 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.82 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -202.76% |
| Net Margin (Trailing 12 Months) | -202.83% |
| Return on Equity (Trailing 12 Months) | -1367.63% |
| Return on Assets (Trailing 12 Months) | -202.97% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.04 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.42 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.74 |
| Book Value per Share (Most Recent Fiscal Quarter) | $62.71 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-107.91 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 1.66M |
| Free Float | 1.33M |
| Market Capitalization | $3.88M |
| Average Volume (Last 20 Days) | 0.04M |
| Beta (Past 60 Months) | -0.17 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 20.08% |
| Percentage Held By Institutions (Latest 13F Reports) | 3.13% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |